Vascular Solutions to Participate in Jefferies 3rd Annual Healthcare Conference

MINNEAPOLIS, June 10, 2009 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc.
(Nasdaq:VASC) today announced that the Company is scheduled to participate in
the Jefferies 3rd Annual Healthcare Conference being held next week in New York
City.

Howard Root, Chief Executive Officer of Vascular Solutions, will present on
Wednesday, June 17th at 4:15pm (EDT). To hear the live audio webcast of the
panel discussion, go to the investor relations page of the Company's web site
http://www.vascularsolutions.com and click on the "IR Conferences" icon a few
minutes prior to start time to download any necessary software.

About Vascular Solutions

Vascular Solutions, Inc. is an innovative medical device company that focuses on
developing unique clinical solutions for coronary and peripheral vascular
procedures. The company's product line consists of five major categories:
hemostat (blood clotting) products, extraction (clot removal) catheters, vein
products, specialty catheters and access products. Vascular Solutions delivers
its proprietary and distributed products to interventional cardiologists,
interventional radiologists and vascular surgeons through its direct U.S. sales
force and international distributor network.

The information in this press release contains forward-looking statements that
involve risks and uncertainties. Our actual results could differ materially from
those anticipated in these forward-looking statements. Important factors that
may cause such differences include those discussed in our Annual Report on Form
10-K for the year ended December 31, 2008 and other recent filings with the
Securities and Exchange Commission. The risks and uncertainties include, without
limitation, risks associated with the need for adoption of our new products,
limited working capital, lack of sustained profitability, exposure to
intellectual property claims, exposure to possible product liability claims, the
development of new products by others, doing business in international markets,
limited manufacturing experience, the availability of third party reimbursement,
and actions by the FDA.

For further information, connect to www.vascularsolutions.com.

-0-
CONTACT: Vascular Solutions, Inc.
Howard Root, CEO
James Hennen, CFO
(763) 656-4300